Vironix Health Inc.

Vironix Health Inc.

AI-Enabled Early Detection and Remote Monitoring of Lung and Heart Disease

Security Type
Preferred Stock
Technology, Software, Hardware, Artificial Intelligence, Community
Min Investment
Austin, TX
Expected Close Date
April 30, 2023
Amount Raised
Target Raise
No. Investors
Security Price

Key Deal Facts

❀️ Vironix Outperforms Standard-of-Care in Detecting/Triaging Heart Failure, COPD & Asthma Flare-ups
πŸ’Έ $150M Potential ARR from Current LOIs (not guaranteed)
πŸ’ͺ APIs Raise Wellness, Scale Globally, & Grow Revenue for Caregivers
πŸ’° $450K Raised in Pre-Seed/Seed capital to date; $350K Invested Into R&D
🀝 World Class R&D Collaboration w/ Oxford University
πŸ“œ Patent Pending on Early Detection Technology (USPTO: 63/316,078)
πŸŽ“ 2021 Mass Challenge Accelerator Alum & ✊ Certified Minority Controlled Enterprise
πŸ“– Peer-Reviewed Publications and Invited Talks w/ Duke, Kaiser-Permanente, & Oxford.

Security Description

Preferred securities are a type of investment that generally offers some sort of preferred treatment through a dividend or preferred treatment in a liquidation.

Research Reports

No reports have been submitted

Become a Reporter